(0.00%) 5 187.67 points
(0.44%) 39 056 points
(-0.18%) 16 303 points
(0.29%) $79.22
(-0.41%) $2.18
(-0.23%) $2 316.90
(-0.06%) $27.59
(0.09%) $985.50
(0.07%) $0.931
(0.17%) $10.91
(0.04%) $0.801
(0.02%) $91.75
Quarter results today
(amc 2024-05-09)
Expected move: +/- 6.70%
-2.86% $ 10.18
@ $8.22
Wydano: 14 vas. 2024 @ 16:30
Zwrot: 23.84%
Poprzedni sygnał: vas. 13 - 16:30
Poprzedni sygnał:
Zwrot: -2.26 %
Live Chart Being Loaded With Signals
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients...
Stats | |
---|---|
Dzisiejszy wolumen | 621 967 |
Średni wolumen | 819 065 |
Kapitalizacja rynkowa | 529.44M |
EPS | $0 ( 2024-02-28 ) |
Następna data zysków | ( $-0.190 ) 2024-05-09 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -2.88 |
ATR14 | $0.0160 (0.16%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-05-01 | Novack Jeffrey Adam | Sell | 1 905 | Common Stock |
2024-04-24 | Novack Jeffrey Adam | Sell | 0 | Common Stock |
2024-04-24 | Novack Jeffrey Adam | Sell | 2 385 | Employee Stock Option (right to buy) |
2024-04-24 | Novack Jeffrey Adam | Sell | 2 150 | Employee Stock Option (right to buy) |
2024-05-01 | Jain Abhishek | Sell | 7 371 | Common Stock |
INSIDER POWER |
---|
8.60 |
Last 100 transactions |
Buy: 1 531 623 | Sell: 918 597 |
Wolumen Korelacja
CareDx Inc Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
INFI | 0.962 |
BAND | 0.958 |
NKTR | 0.955 |
FULC | 0.954 |
INGN | 0.953 |
ORGS | 0.953 |
UPLD | 0.949 |
JAGX | 0.941 |
MICS | 0.936 |
GOODM | 0.934 |
10 Najbardziej negatywne korelacje | |
---|---|
TIG | -0.918 |
TYHT | -0.915 |
MYRG | -0.913 |
SGEN | -0.911 |
OPCH | -0.906 |
PPYAU | -0.898 |
APEN | -0.889 |
RELY | -0.889 |
KNBE | -0.882 |
ALTR | -0.88 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
CareDx Inc Korelacja - Waluta/Towar
CareDx Inc Finanse
Annual | 2023 |
Przychody: | $280.32M |
Zysk brutto: | $175.87M (62.74 %) |
EPS: | $-3.54 |
FY | 2023 |
Przychody: | $280.32M |
Zysk brutto: | $175.87M (62.74 %) |
EPS: | $-3.54 |
FY | 2022 |
Przychody: | $321.79M |
Zysk brutto: | $209.58M (65.13 %) |
EPS: | $-1.440 |
FY | 2021 |
Przychody: | $296.40M |
Zysk brutto: | $199.01M (67.14 %) |
EPS: | $-0.582 |
Financial Reports:
No articles found.
CareDx Inc
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. The company also offers TruSight HLA, a next generation sequencing (NGS) based high resolution typing solution; Olerup SSP, which is used to type human leukocyte antigen (HLA) alleles based on sequence specific primer technology; QTYPE that enables precision in HLA typing; and Ottr, a transplant patient management software. In addition, it provides AlloSeq Tx, a high-resolution HLA typing solution; AlloSeq cfDNA, a surveillance solution to measure dd-cfDNA in blood; AlloSeq HCT, a solution for chimerism testing for stem cell transplant recipients; and XynQAPI transplant quality tracking and waitlist management solutions, as well as AlloCare, a mobile app that offers a patient-centric resource for transplant recipients. The company offers its products directly to customers, as well as through third-party distributors and sub-distributors. It has a license agreement with Illumina, Inc. for the distribution, development, and commercialization of NGS products and technologies; and Cibiltech SAS to commercialize iBox, a software for the predictive analysis of post-transplantation kidney allograft loss. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. The company was incorporated in 1998 and is headquartered in South San Francisco, California.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej